325 related articles for article (PubMed ID: 21799180)
1. ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.
Henderson MJ; Haber M; Porro A; Munoz MA; Iraci N; Xue C; Murray J; Flemming CL; Smith J; Fletcher JI; Gherardi S; Kwek CK; Russell AJ; Valli E; London WB; Buxton AB; Ashton LJ; Sartorelli AC; Cohn SL; Schwab M; Marshall GM; Perini G; Norris MD
J Natl Cancer Inst; 2011 Aug; 103(16):1236-51. PubMed ID: 21799180
[TBL] [Abstract][Full Text] [Related]
2. ABC transporters and neuroblastoma.
Yu DM; Huynh T; Truong AM; Haber M; Norris MD
Adv Cancer Res; 2015; 125():139-70. PubMed ID: 25640269
[TBL] [Abstract][Full Text] [Related]
3. Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas.
Chayka O; Corvetta D; Dews M; Caccamo AE; Piotrowska I; Santilli G; Gibson S; Sebire NJ; Himoudi N; Hogarty MD; Anderson J; Bettuzzi S; Thomas-Tikhonenko A; Sala A
J Natl Cancer Inst; 2009 May; 101(9):663-77. PubMed ID: 19401549
[TBL] [Abstract][Full Text] [Related]
4. Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.
Haber M; Smith J; Bordow SB; Flemming C; Cohn SL; London WB; Marshall GM; Norris MD
J Clin Oncol; 2006 Apr; 24(10):1546-53. PubMed ID: 16575006
[TBL] [Abstract][Full Text] [Related]
5. Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma.
Burkhart CA; Cheng AJ; Madafiglio J; Kavallaris M; Mili M; Marshall GM; Weiss WA; Khachigian LM; Norris MD; Haber M
J Natl Cancer Inst; 2003 Sep; 95(18):1394-403. PubMed ID: 13130115
[TBL] [Abstract][Full Text] [Related]
6. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.
Zhou SF; Wang LL; Di YM; Xue CC; Duan W; Li CG; Li Y
Curr Med Chem; 2008; 15(20):1981-2039. PubMed ID: 18691054
[TBL] [Abstract][Full Text] [Related]
7. Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
Munoz M; Henderson M; Haber M; Norris M
IUBMB Life; 2007 Dec; 59(12):752-7. PubMed ID: 18085475
[TBL] [Abstract][Full Text] [Related]
8. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression.
Liu PY; Erriquez D; Marshall GM; Tee AE; Polly P; Wong M; Liu B; Bell JL; Zhang XD; Milazzo G; Cheung BB; Fox A; Swarbrick A; Hüttelmaier S; Kavallaris M; Perini G; Mattick JS; Dinger ME; Liu T
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24906397
[TBL] [Abstract][Full Text] [Related]
9. N-Myc regulates expression of the detoxifying enzyme glutathione transferase GSTP1, a marker of poor outcome in neuroblastoma.
Fletcher JI; Gherardi S; Murray J; Burkhart CA; Russell A; Valli E; Smith J; Oberthuer A; Ashton LJ; London WB; Marshall GM; Norris MD; Perini G; Haber M
Cancer Res; 2012 Feb; 72(4):845-53. PubMed ID: 22202125
[TBL] [Abstract][Full Text] [Related]
10. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma.
Norris MD; Bordow SB; Marshall GM; Haber PS; Cohn SL; Haber M
N Engl J Med; 1996 Jan; 334(4):231-8. PubMed ID: 8532000
[TBL] [Abstract][Full Text] [Related]
11. BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.
Wyce A; Ganji G; Smitheman KN; Chung CW; Korenchuk S; Bai Y; Barbash O; Le B; Craggs PD; McCabe MT; Kennedy-Wilson KM; Sanchez LV; Gosmini RL; Parr N; McHugh CF; Dhanak D; Prinjha RK; Auger KR; Tummino PJ
PLoS One; 2013; 8(8):e72967. PubMed ID: 24009722
[TBL] [Abstract][Full Text] [Related]
12. Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance.
Balaji SA; Udupa N; Chamallamudi MR; Gupta V; Rangarajan A
PLoS One; 2016; 11(5):e0155013. PubMed ID: 27171227
[TBL] [Abstract][Full Text] [Related]
13. Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behavior.
Matsunaga T; Shirasawa H; Hishiki T; Enomoto H; Kouchi K; Ohtsuka Y; Iwai J; Yoshida H; Tanabe M; Kobayashi S; Asano T; Etoh T; Nishi Y; Ohnuma N
Jpn J Cancer Res; 1998 Dec; 89(12):1276-83. PubMed ID: 10081488
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.
Ikram F; Ackermann S; Kahlert Y; Volland R; Roels F; Engesser A; Hertwig F; Kocak H; Hero B; Dreidax D; Henrich KO; Berthold F; Nürnberg P; Westermann F; Fischer M
Mol Oncol; 2016 Feb; 10(2):344-59. PubMed ID: 26598443
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclin-dependent kinase 1-induced cell death in neuroblastoma cells through the microRNA-34a-MYCN-survivin pathway.
Chen Y; Tsai YH; Tseng SH
Surgery; 2013 Jan; 153(1):4-16. PubMed ID: 22703967
[TBL] [Abstract][Full Text] [Related]
16. Knowing your ABCCs: novel functions of ABCC transporters.
Brodeur GM
J Natl Cancer Inst; 2011 Aug; 103(16):1207-8. PubMed ID: 21799181
[No Abstract] [Full Text] [Related]
17. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.
Chevrier L; Meunier AC; Cochaud S; Muller JM; Chadéneau C
Int J Oncol; 2008 Nov; 33(5):1081-9. PubMed ID: 18949372
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome.
Ryan J; Tivnan A; Fay J; Bryan K; Meehan M; Creevey L; Lynch J; Bray IM; O'Meara A; Tracey L; Davidoff AM; Stallings RL
Br J Cancer; 2012 Sep; 107(6):967-76. PubMed ID: 22892391
[TBL] [Abstract][Full Text] [Related]
20. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
